Caris Life Sciences, Inc.(CAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAI Caris Life Sciences, Inc.

休市中 11-13 16:00:00 EST

23.04

-0.92

-3.84%

盘后23.04

+0.000.00%

19:30 EST

最高24.37	最低22.58	成交量302.13万
今开24.00	昨收23.96	日振幅7.47%
总市值66.08亿	流通市值26.73亿	总股本2.87亿
成交额6,945万	换手率2.60%	流通股本1.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":23.04,"timestamp":1794603600000,"preClose":23.96,"halted":0,"volume":3021313,"hourTrading":{"tag":"盘后","latestPrice":23.04,"preClose":23.04,"latestTime":"19:30 EST","volume":57157,"amount":1316900.25,"timestamp":1794616202918,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.038397328881469184,"floatShares":115999999,"shares":286784504,"eps":0.333243,"marketStatus":"休市中","change":-0.92,"latestTime":"11-13 16:00:00 EST","open":24,"high":24.37,"low":22.58,"amount":69449755.704182,"amplitude":0.074708,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.333243,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":23.96,"preHourTrading":{"tag":"盘前","latestPrice":23.73,"preClose":23.96,"latestTime":"08:32 EST","volume":1385,"amount":33254.88321,"timestamp":1794576763883,"change":-0.23,"changeRate":-0.009599,"amplitude":0.050918},"postHourTrading":{"tag":"盘后","latestPrice":23.04,"preClose":23.04,"latestTime":"19:30 EST","volume":57157,"amount":1316900.25,"timestamp":1794616202918,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5296847462607722,"impliedVol":0.9473,"impliedVolPercentile":0.9363},"requestUrl":"/m/hq/s/CAI","defaultTab":"news","newsList":[{"id":"1149716926","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌4.19%，财报后抛压延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1149716926","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149716926?lang=zh_cn&edition=full","pubTime":"2026-11-13 23:05","pubTimestamp":1794582333,"startTime":"0","endTime":"0","summary":"11月13日，Caris Life Sciences, Inc.盘中下跌4.19%，报22.975美元/股，成交额516.56万美元。消息面上，公司此前披露的第三季度业绩虽超预期并上调全年营收指引，但财报后抛压仍未完全消化，股价继续承压。公司第三季度每股收益0.05美元，高于市场预期的0.03至0.04美元；营收2.754亿美元，高于预期的约2.554亿美元，并将全年营收指引上调至10.4亿至10.5亿美元。不过，其每股收益仍低于上年同期的0.08美元，且近期机构观点仍有分歧，市场对估值与增长持续性保持谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后抛压延续，Caris Life Sciences盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196010207","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌4.37%，财报后抛压延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1196010207","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196010207?lang=zh_cn&edition=full","pubTime":"2026-11-12 22:55","pubTimestamp":1794495322,"startTime":"0","endTime":"0","summary":"11月12日，Caris Life Sciences, Inc.盘中下跌4.37%，报23.74美元/股，成交额468.42万美元。消息面上，公司虽在此前披露的第三季度业绩中实现营收与每股收益双双超预期，并上调全年营收指引，但财报后股价一度大跌逾20%，近期市场抛压仍未完全消化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后抛压延续，Caris Life Sciences盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195236407","title":"异动解读｜Caris Life Sciences, Inc.盘中上涨4.46%，财报后反弹叠加新研究入组进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1195236407","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195236407?lang=zh_cn&edition=full","pubTime":"2026-11-11 22:50","pubTimestamp":1794408632,"startTime":"0","endTime":"0","summary":"11月11日，Caris Life Sciences, Inc.盘中上涨4.46%，报25.185美元/股，成交额414.6万美元。消息面上，公司此前第三季度业绩超预期并上调全年营收指引，财报后在连续抛压后出现反弹；同日公司还宣布髓系肿瘤基因组测序研究已完成首批患者入组。公司第三季度EPS为0.05美元，高于市场预期的0.03至0.04美元，营收2.754亿美元，同比由2.168亿美元增长，并高于约2.554亿美元预期；全年营收指引上调至10.4亿至10.5亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Caris财报超预期，盘中异动上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185057363","title":"异动解读｜Caris Life Sciences, Inc.盘前上涨4.79%，财报后空头回补叠加机构分歧延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1185057363","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185057363?lang=zh_cn&edition=full","pubTime":"2026-11-11 20:15","pubTimestamp":1794399345,"startTime":"0","endTime":"0","summary":"11月11日，Caris Life Sciences, Inc.盘前上涨4.79%，报25.6美元/股，成交额9.62万美元。消息面上，公司此前披露的第三季度业绩好于预期，且上调全年营收指引，财报后持续抛压后股价出现反弹。不过，其每股收益仍低于上年同期的0.08美元，且近期机构观点继续分化，Citigroup维持买入、Piper Sandler维持中性，反映市场对估值与增长持续性仍有分歧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报超预期上调指引，盘前强势反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187825241","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌5.2%，财报后抛压延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1187825241","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187825241?lang=zh_cn&edition=full","pubTime":"2026-11-10 23:51","pubTimestamp":1794325860,"startTime":"0","endTime":"0","summary":"11月10日，Caris Life Sciences, Inc.盘中下跌5.2%，报24.24美元/股，成交额1881.41万美元。消息面上，公司此前披露的第三季度业绩虽超预期，但财报后股价持续承压，最新机构评级亦仅显示分化延续。但每股收益仍低于上年同期的0.08美元，此前财报发布后股价一度大跌逾20%，近日Citigroup维持买入、Piper Sandler维持中性，显示市场对估值与增长持续性仍存分歧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后抛压延续，Caris盘中下跌","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194408568","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌5.11%，财报后股价持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1194408568","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194408568?lang=zh_cn&edition=full","pubTime":"2026-11-06 23:30","pubTimestamp":1793979035,"startTime":"0","endTime":"0","summary":"11月6日，Caris Life Sciences, Inc.盘中下跌5.11%，报24.705美元/股，成交额4584.44万美元。消息面上，公司最新披露的第三季度业绩虽高于市场预期，但每股收益同比由0.08美元降至0.05美元，财报发布后股价持续承压。公司同时将全年营收指引上调至10.4亿至10.5亿美元，高于此前的10.3亿至10.4亿美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后持续承压，盘中走低引关注","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164849065","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌18.12%，财报后股价持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1164849065","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164849065?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:44","pubTimestamp":1793889895,"startTime":"0","endTime":"0","summary":"11月5日，Caris Life Sciences, Inc.盘中下跌18.12%，报25.8美元/股，成交额2770.96万美元。消息面上，公司最新披露的第三季度业绩虽高于市场预期，但每股收益同比由0.08美元降至0.05美元，财报发布后股价持续承压。公司同时将全年营收指引上调至10.4亿至10.5亿美元，高于此前的10.3亿至10.4亿美元。Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立，并于2020年7月在德克萨斯州重新注册成立，总部位于德克萨斯州欧文。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后股价承压，Caris盘中下跌","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165888302","title":"异动解读｜Caris Life Sciences, Inc.盘前下跌11.32%，财报后股价承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1165888302","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165888302?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:02","pubTimestamp":1793869369,"startTime":"0","endTime":"0","summary":"11月5日，Caris Life Sciences, Inc.盘前下跌11.32%，报28.95美元/股，成交额8276.01美元。消息面上，公司最新披露的第三季度业绩虽高于市场预期，但每股收益同比由0.08美元降至0.05美元，财报发布后股价承压。公司同时将全年营收指引上调至10.4亿至10.5亿美元，高于此前的10.3亿至10.4亿美元。Caris Life Sciences, Inc.是一家以患者为中心的下一代AI科技生物公司和精准医疗企业，专注于通过综合分子信息和人工智能技术推动肿瘤学等领域的精准医疗应用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后股价承压，AI精准医疗股盘前下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188026664","title":"异动解读｜Caris Life Sciences, Inc.夜盘下跌13.46%，财报后股价承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1188026664","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188026664?lang=zh_cn&edition=full","pubTime":"2026-11-05 10:02","pubTimestamp":1793844167,"startTime":"0","endTime":"0","summary":"11月5日，Caris Life Sciences, Inc.夜盘下跌13.46%，报28.75美元/股，成交额863.0美元。消息面上，公司最新披露的第三季度业绩虽高于市场预期，但每股收益同比由0.08美元降至0.05美元，财报发布后股价承压。具体来看，公司第三季度营收2.754亿美元，高于市场预期的2.554亿美元，上年同期为2.168亿美元；每股收益0.05美元，高于预期的0.03美元。公司同时将全年营收指引上调至10.4亿至10.5亿美元，高于此前的10.3亿至10.4亿美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报后夜盘大跌，Caris股价承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175070500","title":"异动解读｜Caris Life Sciences, Inc.盘后下跌9.36%，财报后股价承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1175070500","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175070500?lang=zh_cn&edition=full","pubTime":"2026-11-05 05:09","pubTimestamp":1793826555,"startTime":"0","endTime":"0","summary":"11月5日，Caris Life Sciences, Inc.盘后下跌9.36%，报30.1102美元／股，成交额147.3万美元。消息面上，公司此前披露的业绩一致预期虽仍指向高增长，但财报前后股价波动明显，最新公开信息显示，市场曾围绕持股变动披露与财报前资金观望展开交易。公开数据显示，公司此前市场一致预期本季度营收为2.55亿美元，同比增长50.08%，调整后每股收益预计为0.03美元，EBIT预计为1618.23万美元；同时，公司近日曾披露多份Form 4及144文件，涉及持股变动声明与拟议证券出售报告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报后股价承压，盘后异动下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177571438","title":"异动解读｜Caris Life Sciences, Inc.盘中上涨5.48%，财报前业绩预期向好叠加机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1177571438","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177571438?lang=zh_cn&edition=full","pubTime":"2026-11-03 23:21","pubTimestamp":1793719269,"startTime":"0","endTime":"0","summary":"11月3日，Caris Life Sciences, Inc.盘中上涨5.48%，报33.86美元／股，成交额1364.4万美元。消息面上，公司在财报披露前夕的业绩一致预期维持高增长，叠加机构总体观点偏多，带动股价走强。市场一致预期显示，公司本季度营收预计为2.55亿美元，同比增长50.08%；调整后每股收益预计为0.03美元，EBIT预计为1618.23万美元。此前BofA Securities将其目标价由23美元上调至35美元，市场平均评级为overweight。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Caris Life Sciences盘中上涨，财报前业绩预期向好","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165698244","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌5.04%，财报前夕资金观望叠加持股变动披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1165698244","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165698244?lang=zh_cn&edition=full","pubTime":"2026-11-03 01:35","pubTimestamp":1793640902,"startTime":"0","endTime":"0","summary":"11月3日，Caris Life Sciences, Inc.盘中下跌5.04%，报32.6美元／股，成交额3899.01万美元。消息面上，公司近日披露多份Form 4及144文件，涉及持股变动声明与拟议证券出售报告，叠加财报发布前夕，市场情绪偏谨慎。与此同时，机构总体观点仍偏多。此前BofA Securities将其目标价由23美元上调至35美元，市场平均评级为overweight，平均目标价为27.08美元；一致预期显示，公司本季度营收预计2.55亿美元，同比增长50.08%，调整后每股收益预计0.03美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前夕现持股变动，Caris Life Sciences盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124670924","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌5.42%，报34.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124670924","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124670924?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:20","pubTimestamp":1793370011,"startTime":"0","endTime":"0","summary":"10月30日，Caris Life Sciences, Inc.盘中下跌5.42%，报34.15美元/股，成交额3669.4万美元。Caris Life Sciences, Inc.所在的生物科技行业中，个股表现分化，再生元制药公司上涨11.88%，Moderna, Inc.下跌2.02%，艾伯维公司上涨1.1%，吉利德科学上涨3.79%，福泰制药上涨2.04%。Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立，并于2020年7月在德克萨斯州重新注册成立，总部位于德克萨斯州欧文。他们是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104889539","title":"异动解读｜Caris Life Sciences, Inc.盘中上涨5.11%，财报预期高增叠加投行上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1104889539","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104889539?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:55","pubTimestamp":1793195713,"startTime":"0","endTime":"0","summary":"10月28日，Caris Life Sciences, Inc.盘中上涨5.11%，报35.39美元/股，成交额1080.54万美元。此次异动的消息面，主要与公司财报预期改善及机构看多态度延续有关。市场一致预期显示，公司将于11月4日披露的季度营收预计为2.55亿美元，同比增长50.08%；调整后每股收益预计为0.03美元，同比提升115.40%；EBIT预计为1618.23万美元，同比提升180.48%。同时，BofA Securities于10月9日将其目标价上调至35美元，市场平均评级为overweight，均值目标价为27.08美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报预期高增，Caris Life Sciences盘中上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161455253","title":"财报前瞻 | Caris Life Sciences, Inc.本季度营收预计增长50.08%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1161455253","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161455253?lang=zh_cn&edition=full","pubTime":"2026-10-28 10:47","pubTimestamp":1793155645,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc.将于2026年11月04日发布最新财报，本文基于近六个月公开信息与一致预期梳理市场焦点与核心变动。市场一致预期显示，本季度Caris Life Sciences, Inc.营收预计为2.55亿美元，同比增长50.08%；毛利率未披露；净利润或净利率未披露；调整后每股收益预计为0.03美元，同比提升115.40%；EBIT预计为1,618.23万美元，同比提升180.48%。根据市场一致预期，本季度总营收预计增长50.08%，若分子分析服务维持主导地位，其检测试剂与服务订单的放量是主要驱动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | Caris Life Sciences, Inc.本季度营收预计增长50.08%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128503315","title":"异动解读｜Caris Life Sciences盘中下跌5.24%，报30.655美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128503315","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128503315?lang=zh_cn&edition=full","pubTime":"2026-10-23 00:41","pubTimestamp":1792687261,"startTime":"0","endTime":"0","summary":"10月23日，Caris Life Sciences盘中下跌5.24%，报30.655美元/股，成交额2221.86万美元。Caris Life Sciences所在的生物科技行业中，Moderna, Inc.下跌14.84%，艾伯维公司下跌0.72%，安进上涨2.1%，Argenx SE下跌1.54%，Biohaven Pharmaceutical Holding Co Ltd.上涨24.43%。公司是一家以患者为中心的下一代AI科技生物公司，聚焦精准医疗，初期重点布局肿瘤学，并服务临床、学术和生物制药市场。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134940341","title":"异动解读｜Caris Life Sciences, Inc.盘中下跌5.05%，目标价上调利好后短线回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1134940341","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134940341?lang=zh_cn&edition=full","pubTime":"2026-10-17 03:09","pubTimestamp":1792177798,"startTime":"0","endTime":"0","summary":"10月17日，Caris Life Sciences, Inc.盘中下跌5.05%，报30.1611美元/股，成交额5411.34万美元。近期消息面上，美国银行证券将公司目标价从23美元上调至35美元，显著高于27.08美元的市场平均目标价；不过在此前股价连续走强后，利好对当日盘面支撑有限。基本面方面，公司二季度营收2.637亿美元，高于市场预期的2.381亿美元；一季度营收2.162亿美元，同比增长79%，并实现盈亏平衡，同时维持全年10亿至10.2亿美元营收指引，显示经营改善趋势仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"目标价获上调，短线回吐下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103328137","title":"异动解读｜Caris Life Sciences, Inc.盘中上涨5.11%，目标价上调至35美元提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1103328137","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103328137?lang=zh_cn&edition=full","pubTime":"2026-10-16 03:07","pubTimestamp":1792091224,"startTime":"0","endTime":"0","summary":"10月16日，Caris Life Sciences, Inc.盘中上涨5.11%，报31.8美元/股，成交额6697.18万美元。消息面上，美国银行证券近期将公司目标价从23美元上调至35美元，明显高于27.08美元的市场平均目标价，带动市场风险偏好回升。基本面方面，公司二季度营收2.637亿美元，高于市场预期的2.381亿美元；一季度营收2.162亿美元，同比增长79%，并实现盈亏平衡，同时维持全年10亿至10.2亿美元营收指引，强化了估值修复逻辑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"目标价获大幅上调，Caris Life Sciences盘中上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163653755","title":"异动解读｜Caris Life Sciences, Inc.盘中上涨5.99%，目标价获上调至35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163653755","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163653755?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:04","pubTimestamp":1791986642,"startTime":"0","endTime":"0","summary":"10月14日，Caris Life Sciences, Inc.盘中上涨5.99%，报31.345美元/股，成交额1367.84万美元。近期消息面上，美国银行证券将公司目标价从23美元上调至35美元，明显高于此前27.08美元的市场平均目标价，提振了市场情绪。此前公司二季度营收达2.637亿美元，高于市场预期的2.381亿美元；一季度营收2.162亿美元，同比增长79%，并实现盈亏平衡，同时维持全年10亿至10.2亿美元营收指引，基本面改善为估值修复提供支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Caris Life Sciences获美银上调目标价，盘中强势上涨","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138312180","title":"异动解读｜Caris Life Sciences盘中上涨5.07%，美银上调目标价提振精准医疗板块情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1138312180","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138312180?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:09","pubTimestamp":1791554958,"startTime":"0","endTime":"0","summary":"10月9日，Caris Life Sciences盘中上涨5.07%，报28.895美元/股，成交额786.59万美元。此前公司第二季度财报显示营收达2.637亿美元，显著超过市场预期的2.381亿美元；同时其在精准肿瘤学领域持续拓展，PTEN IHC检测的推出及Caris Chromoseq获Moldx批准等进展，持续强化市场对其AI驱动精准医疗平台的信心。Caris Life Sciences所在的生物科技行业中，个股表现分化，其中Twist Bioscience Corp涨8.39%，Moderna涨8.16%，Natera涨3.7%，安进涨1.04%，艾伯维公司涨1.01%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美银大幅上调目标价，Caris盘中拉升","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0868},{"period":"1month","weight":-0.2385},{"period":"3month","weight":0.0569},{"period":"6month","weight":0.5835},{"period":"1year","weight":-0.0519},{"period":"ytd","weight":-0.146}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立，并于2020年7月在德克萨斯州重新注册成立，总部位于德克萨斯州欧文。他们是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱。他们开发并商业化创新解决方案，通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健。他们的整个精准医疗解决方案组合旨在造福患者，最初的重点是肿瘤学，并服务于临床、学术和生物制药市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caris Life Sciences, Inc.(CAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caris Life Sciences, Inc.(CAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}